PLYXPolaryx Therapeutics, Inc.
PLYX holders
Who holds Polaryx Therapeutics, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Moves this quarter
Added
- State Street Corp+9.9K$140.8K
- UBS Group AG+3.1K$9K
Reduced
- HRT Financial LP−49K$68
- Geode Capital Management, LLC−32.2K$287.4K
- Vanguard Fiduciary Trust Co−24.8K$166.3K
- Vanguard Capital Management LLC−2K$3.4M
- Tower Research Capital LLC (TRC)−1.1K$3.8K
New
- Cerity Partners LLC10.4K$21.6K
- Barclays PLC9$19
- Managers
- 13
- Shares held
- 2.1M
- Value held
- $4.2M
- Opened
- 2
- Closed
- 2
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 1.7M | −0.1% | $3.4M | 0.1% | Nov 13, 2026 |
| Geode Capital Management, LLC | 138.8K | −18.9% | $287.4K | 0% | Nov 6, 2026 |
| Vanguard Fiduciary Trust Co | 80.3K | −23.6% | $166.3K | 0% | Nov 13, 2026 |
| State Street Corp | 68K | +17.0% | $140.8K | 0% | Nov 12, 2026 |
| BlackRock, Inc. | 41K | ±0% | $84.9K | 0% | Nov 13, 2026 |
| Northern Trust Corp | 28K | ±0% | $57.9K | 0% | Nov 16, 2026 |
| Cerity Partners LLC | 10.4K | New | $21.6K | 0% | Nov 13, 2026 |
| Allworth Financial LP | 7.7K | ±0% | $16K | 0.1% | Nov 17, 2026 |
| Vanguard Global Advisers, LLC | 6.3K | ±0% | $13.1K | 0% | Nov 13, 2026 |
| UBS Group AG | 4.4K | +239.4% | $9K | 0% | Nov 10, 2026 |
| Tower Research Capital LLC (TRC) | 1.9K | −38.2% | $3.8K | 0% | Nov 16, 2026 |
| HRT Financial LP | 33.1K | −59.7% | $68 | 0.1% | Nov 13, 2026 |
| Barclays PLC | 9 | New | $19 | 0% | Nov 6, 2026 |